Fingerprint
Dive into the research topics of 'Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Saba S. Shaikh, Yan Zang, Janel Hanmer, Hong Wang, Yan Lin, Diwakar Davar, Hassane M. Zarour, John M. Kirkwood, Yana G. Najjar
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations